Seikon1
☕ Support

EDGAR Filings (All Forms)

SEC submissions(JSON) 기반으로 모든 Form을 나열합니다. (8-K, F-1, EFFECT 등)

A. Ticker 또는 CIK로 Filings 조회

Tip: ticker만 입력해도 서버에서 CIK로 자동 변환해 조회합니다.
Resolved: AZN → 0000901832 (ASTRAZENECA PLC)
ASTRAZENECA PLC
CIK: 0000901832 • Tickers: AZN
cached: false
FiledFormAccessionPrimary DocSEC IndexSEC DocParse
2026-06-1640001104659-26-074570xslF345X06/tm2617978-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-06-156-K0001654954-26-005964a1987i.htm
TRUQAP APPROVED IN US FOR PROSTATE CANCER
Checking…SEC DocChecking…
2026-06-016-K0001654954-26-005587a4701g.htm
ADMISSION OF FURTHER SECURITIES TO TRADING
Checking…SEC DocChecking…
2026-06-016-K0001654954-26-005586a4717g.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-05-296-K0001654954-26-005498a1377g.htm
IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
Checking…SEC DocChecking…
2026-05-2825-NSE0000876661-26-000484xslF25X02/primary_doc.xmlChecking…SEC DocChecking…
2026-05-276-K0001654954-26-005381a7798f.htm
US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005309a6573f.htm
DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005306a6571f.htm
ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005303a6568f.htm
CAMIZESTRANT RECOMMENDED FOR BREAST CANCER IN EU
Checking…SEC DocChecking…
2026-05-2240001104659-26-065693xslF345X06/tm2615366-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005049a7391e.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005044a6161e.htm
BAXFENDY APPROVED IN THE US FOR HYPERTENSION
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005038a6159e.htm
ENHERTU APPROVED IN TWO HER2+ EARLY BC SETTINGS
Checking…SEC DocChecking…
2026-05-146-K0001654954-26-004836a3223e.htm
IMFINZI + EV IMPROVES EFS & OS IN BLADDER CANCER
Checking…SEC DocChecking…
2026-05-0840001104659-26-057906xslF345X06/tm2614063-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004247a8007c.htm
TOTAL VOTING RIGHTS AND ADMISSION OF SHARES
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004229a7028c.htm
FDA ODAC VOTE ON CAMIZESTRANT IN BREAST CANCER
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004226a7026c.htm
FDA ODAC RECOMMENDS TRUQAP IN PROSTATE CANCER
Checking…SEC DocChecking…
2026-04-296-K0001654954-26-004047a2999c.htm
1ST QUARTER RESULTS
Checking…SEC DocChecking…
2026-04-28SCHEDULE 13G0002100119-26-000022xslSCHEDULE_13G_X02/primary_doc.xmlChecking…SEC DocChecking…
2026-04-286-K0001654954-26-003979a1866c.htm
BREZTRI APPROVED IN THE US FOR ASTHMA
Checking…SEC DocChecking…
2026-04-276-K0001654954-26-003936a9587b.htm
SAPHNELO SELF-ADMINISTRATION APPROVED IN THE US
Checking…SEC DocChecking…
2026-04-236-K0001654954-26-003818a5427b.htm
DIRECTORATE CHANGE
Checking…SEC DocChecking…
2026-04-216-K0001654954-26-003757a2016b.htm
I CAN PHIII INTERIM ANALYSIS MET PRIMARY ENDPOINT
Checking…SEC DocChecking…
2026-04-206-K0001654954-26-003703a0190b.htm
THIRD TOZORAKIMAB POSITIVE PHASE III IN COPD
Checking…SEC DocChecking…
2026-04-096-K0001654954-26-003374a8862z.htm
RESULT OF AGM
Checking…SEC DocChecking…
2026-04-0825-NSE0000876661-26-000343xslF25X02/primary_doc.xmlChecking…SEC DocChecking…
2026-04-026-K0001654954-26-003206a2331z.htm
IMFINZI+IMJUDO IMPROVES PFS IN EARLY LIVER CANCER
Checking…SEC DocChecking…
2026-04-016-K0001654954-26-003157a9429y.htm
TOTAL VOTING RIGHTS AND ADMISSION OF SHARES
Checking…SEC DocChecking…
2026-03-316-K0001654954-26-003013a7230y.htm
EFZIMFOTASE ALFA PH3 PROGRAM SHOW POSITIVE RESULTS
Checking…SEC DocChecking…
2026-03-276-K0001654954-26-002860a4270y.htm
TOZORAKIMAB MET OBERON/TITANIA PRIMARY ENDPOINTS
Checking…SEC DocChecking…
2026-03-206-K0001654954-26-002523a3904x.htm
NOTIFICATION OF ADMISSION OF SHARES
Checking…SEC DocChecking…
2026-03-1930001104659-26-032249xslF345X06/tm269379-1_3seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-03-166-K0001654954-26-002272a7541w.htm
IMFINZI APPROVED IN EU FOR EARLY GASTRIC CANCER
Checking…SEC DocChecking…
2026-03-106-K0001654954-26-002077a0663w.htm
NOTICE OF AGM
Checking…SEC DocChecking…
2026-03-106-K0001104659-26-025559tm268365d1_6k.htm
FORM 6-K
Checking…SEC DocChecking…
2026-03-066-K0001654954-26-001966a6803v.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-03-066-K0001654954-26-001963a6797v.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-03-066-K0001654954-26-001961a6795v.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-03-04CERT0000876661-26-000201AZN31B33A36030426.pdf
NYSE CERTIFICATION
Checking…SEC DocChecking…
2026-03-038-A12B0001104659-26-022824tm267648d1_8a12b.htm
FORM 8-A12B
Checking…SEC DocChecking…
2026-03-026-K0001104659-26-022240tm267648d3_6k.htm
FORM 6-K
Checking…SEC DocChecking…
2026-03-026-K0001654954-26-001728a7886u.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-02-27424B20001104659-26-021545tm267138-4_424b2.htm
424B2
Checking…SEC DocChecking…
2026-02-266-K0001654954-26-001589a4537u.htm
ASTRAZENECA PRICES A $2BN BOND OFFERING
Checking…SEC DocChecking…
2026-02-26FWP0001104659-26-019812tm267138d5_fwp.htm
FWP
Checking…SEC DocChecking…
2026-02-256-K0001654954-26-001536a0829u.htm
FILING OF FORM 20-F WITH SEC
Checking…SEC DocChecking…
2026-02-25424B20001104659-26-019420tm267138-2_424b2.htm
424B2
Checking…SEC DocChecking…
2026-02-24IRANNOTICE0001104659-26-019141tm261135d2_irannotice.htm
IRANNOTICE
Checking…SEC DocChecking…
Tip: forms 필터 예) 8-K,10-Q,F-1